NYSE:CLVT Clarivate (CLVT) Stock Price, News & Analysis → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free CLVT Stock Alerts $6.24 +0.08 (+1.30%) (As of 05/9/2024 ET) Add Compare Share Share Today's Range$6.08▼$6.2950-Day Range$6.16▼$7.6552-Week Range$6.07▼$10.03Volume3.43 million shsAverage Volume4.11 million shsMarket Capitalization$4.17 billionP/E RatioN/ADividend YieldN/APrice Target$7.78 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Clarivate alerts: Email Address Clarivate MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside24.6% Upside$7.78 Price TargetShort InterestBearish10.34% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.21Based on 22 Articles This WeekInsider TradingN/AProj. Earnings Growth8.06%From $0.62 to $0.67 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.65 out of 5 starsComputer And Technology Sector226th out of 593 stocksData Processing & Preparation Industry14th out of 59 stocks 3.0 Analyst's Opinion Consensus RatingClarivate has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 3 buy ratings, 3 hold ratings, and 3 sell ratings.Amount of Analyst CoverageClarivate has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Clarivate's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.34% of the float of Clarivate has been sold short.Short Interest Ratio / Days to CoverClarivate has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in Clarivate has recently increased by 3.36%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldClarivate does not currently pay a dividend.Dividend GrowthClarivate does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLVT. Previous Next 2.3 News and Social Media Coverage News SentimentClarivate has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 22 news articles for Clarivate this week, compared to 4 articles on an average week.Search Interest2 people have searched for CLVT on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Clarivate to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clarivate insiders have not sold or bought any company stock.Percentage Held by Insiders23.14% of the stock of Clarivate is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions85.72% of the stock of Clarivate is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Clarivate's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Clarivate are expected to grow by 8.06% in the coming year, from $0.62 to $0.67 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clarivate is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clarivate is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioClarivate has a PEG Ratio of 1.41. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioClarivate has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Clarivate's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. About Clarivate Stock (NYSE:CLVT)Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.Read More CLVT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLVT Stock News HeadlinesMay 9, 2024 | markets.businessinsider.comClarivate’s Underwhelming Growth and Subdued Outlook Prompt Underperform RatingMay 9, 2024 | markets.businessinsider.comCritical Insights From Clarivate Analyst Ratings: What You Need To KnowMay 10, 2024 | Stansberry Research (Ad)Things Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.May 9, 2024 | prnewswire.comOMRON Selects IPfolio from ClarivateMay 8, 2024 | msn.comCLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024May 8, 2024 | seekingalpha.comClarivate Plc 2024 Q1 - Results - Earnings Call PresentationMay 8, 2024 | finanznachrichten.deClarivate Plc: Clarivate Reports First Quarter 2024 ResultsMay 8, 2024 | seekingalpha.comClarivate Analytics Non-GAAP EPS of $0.14 in-line, revenue of $621.2M beats by $6.35MMay 10, 2024 | Stansberry Research (Ad)Things Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.May 8, 2024 | markets.businessinsider.comClarivate Posts Loss In Q1; Reaffirms FY24 OutlookMay 8, 2024 | finance.yahoo.comClarivate PLC (CLVT) Q1 2024 Earnings: Mixed Results Amidst Operational ChallengesMay 8, 2024 | finance.yahoo.comShareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years agoMay 8, 2024 | prnewswire.comClarivate Reports First Quarter 2024 ResultsMay 7, 2024 | finanznachrichten.deClarivate Plc: Clarivate Introduces Epidemiology Intelligence for Precision Patient Population AnalysisMay 7, 2024 | prnewswire.comClarivate Introduces Epidemiology Intelligence™ for Precision Patient Population AnalysisMay 5, 2024 | americanbankingnews.comAnalyzing Clarivate (NYSE:CLVT) and DATATRAK International (OTCMKTS:DTRK)May 2, 2024 | prnewswire.comClarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory SuccessMay 1, 2024 | prnewswire.comClarivate Declares Dividend on Mandatory Convertible Preferred SharesMay 1, 2024 | americanbankingnews.comClarivate (CLVT) Scheduled to Post Quarterly Earnings on WednesdayApril 30, 2024 | prnewswire.comBioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special ReportApril 24, 2024 | prnewswire.comClarivate joins United Nations SDG Publishers CompactApril 23, 2024 | msn.comClarivate acquires Global QMSApril 23, 2024 | prnewswire.comClarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New MarketsApril 18, 2024 | morningstar.comClarivate PLC Ordinary SharesApril 17, 2024 | finance.yahoo.comClarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device MarketsApril 16, 2024 | finance.yahoo.comClarivate Plc (NYSE:CLVT): When Will It Breakeven?April 15, 2024 | finance.yahoo.comClarivate Plc (CLVT) Stock Historical Prices & Data - Yahoo FinanceSee More Headlines Receive CLVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today5/09/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Data processing & preparation Sub-IndustryN/A Current SymbolNYSE:CLVT CUSIPN/A CIK1764046 Webwww.clarivate.com Phone442074334000FaxN/AEmployees12,000Year FoundedN/APrice Target and Rating Average Stock Price Target$7.78 High Stock Price Target$10.00 Low Stock Price Target$6.00 Potential Upside/Downside+28.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.48) Trailing P/E RatioN/A Forward P/E Ratio10.06 P/E Growth1.41Net Income$-911,200,000.00 Net Margins-34.66% Pretax Margin-38.52% Return on Equity9.95% Return on Assets3.89% Debt Debt-to-Equity Ratio1.03 Current Ratio0.91 Quick Ratio0.91 Sales & Book Value Annual Sales$2.63 billion Price / Sales1.59 Cash Flow$1.66 per share Price / Cash Flow3.76 Book Value$6.93 per share Price / Book0.90Miscellaneous Outstanding Shares668,140,000Free Float513,535,000Market Cap$4.17 billion OptionableOptionable Beta1.24 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jonathan Gear (Age 53)CEO & Director Comp: $1.9MMr. Jonathan M. Collins (Age 44)Executive VP & CFO Comp: $1.31MMr. Gordon Samson (Age 58)President of Intellectual Property Comp: $1.08MMr. Bar Veinstein (Age 51)President of Academia & Government Comp: $1.1MMr. Henry Levy (Age 51)President of Life Sciences & Healthcare Comp: $1.05MMr. Michael Easton (Age 51)Senior VP of Finance & Chief Accounting Officer Mr. William E. GraffExecutive VP & Chief Information OfficerMr. Mark J. DonohueHead of Investor RelationsMs. Melanie D. Margolin J.D. (Age 52)Chief Legal Officer & Secretary Ms. Tabita AnderssonSenior Vice President of Communications & BrandMore ExecutivesKey CompetitorsFive9NASDAQ:FIVNPegasystemsNASDAQ:PEGAStoneCoNASDAQ:STNEDXC TechnologyNYSE:DXCBilibiliNASDAQ:BILIView All CompetitorsInstitutional OwnershipState Board of Administration of Florida Retirement SystemBought 11,052 shares on 5/9/2024Ownership: 0.067%Edmond DE Rothschild Holding S.A.Bought 1,122,650 shares on 5/8/2024Ownership: 0.581%Russell Investments Group Ltd.Sold 291,004 shares on 5/8/2024Ownership: 0.186%Swiss National BankSold 10,500 shares on 5/7/2024Ownership: 0.088%Oppenheimer Asset Management Inc.Sold 19,979 shares on 5/7/2024Ownership: 0.040%View All Institutional Transactions CLVT Stock Analysis - Frequently Asked Questions Should I buy or sell Clarivate stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last year. There are currently 3 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLVT, but not buy additional shares or sell existing shares. View CLVT analyst ratings or view top-rated stocks. What is Clarivate's stock price target for 2024? 9 Wall Street analysts have issued twelve-month price objectives for Clarivate's shares. Their CLVT share price targets range from $6.00 to $10.00. On average, they predict the company's stock price to reach $7.78 in the next year. This suggests a possible upside of 24.6% from the stock's current price. View analysts price targets for CLVT or view top-rated stocks among Wall Street analysts. How have CLVT shares performed in 2024? Clarivate's stock was trading at $9.26 at the beginning of 2024. Since then, CLVT shares have decreased by 32.6% and is now trading at $6.24. View the best growth stocks for 2024 here. Are investors shorting Clarivate? Clarivate saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 36,900,000 shares, an increase of 8.8% from the March 15th total of 33,920,000 shares. Based on an average trading volume of 3,970,000 shares, the days-to-cover ratio is presently 9.3 days. Approximately 10.0% of the shares of the company are short sold. View Clarivate's Short Interest. When is Clarivate's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our CLVT earnings forecast. How were Clarivate's earnings last quarter? Clarivate Plc (NYSE:CLVT) posted its quarterly earnings results on Tuesday, February, 27th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.21. The business earned $683.70 million during the quarter, compared to the consensus estimate of $687.80 million. Clarivate had a positive trailing twelve-month return on equity of 9.95% and a negative net margin of 34.66%. The business's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.20 EPS. What ETF holds Clarivate's stock? Ranger Equity Bear ETF holds 130,000 shares of CLVT stock, representing -1.28% of its portfolio. What guidance has Clarivate issued on next quarter's earnings? Clarivate updated its FY24 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of $0.70-0.80 for the period, compared to the consensus EPS estimate of $0.74. The company issued revenue guidance of $2.57-2.67 billion, compared to the consensus revenue estimate of $2.62 billion. Who are Clarivate's major shareholders? Clarivate's stock is owned by a variety of institutional and retail investors. Top institutional investors include Exor N.V. (10.07%), Raymond James & Associates (0.91%), Perpetual Ltd (0.89%), Edmond DE Rothschild Holding S.A. (0.58%), Confluence Investment Management LLC (0.37%) and Russell Investments Group Ltd. (0.19%). Insiders that own company stock include Andrew Miles Snyder, Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel. View institutional ownership trends. How do I buy shares of Clarivate? Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CLVT) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarivate Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.